Monica Stonehill

“[Acute pancreatitis] is a major cause of acute hospital admission, which accounts for at least 300,000 patients every year in the U.S., over

celiac disease , including anemia, iron deficiency and “continued mucosal damage in the small intestine,” according to a presenter.

“We undertook this research to explore how food insecurity, a modifiable social determinant of health, might be associated with liver transplant outcomes ,” Ashley H.

“ Alcohol-associated liver disease , or ALD, is a common cause of cirrhosis and a leading indication for liver transplantation in the United States,” Alex R.

autoimmune hepatitis , especially among those aged older than 50 years and with lower IgG levels, according to a presenter.

SAN DIEGO — Glucagon-like peptide-1 receptor agonists may help alleviate risk for adverse liver outcomes, particularly hepatic decompensation, among patients with type 2 diabetes and alcohol-associated liver disease.

SAN DIEGO — Liver stiffness measurements may help predict the risk for hepatocellular carcinoma in patients with metabolic dysfunction-associated

SAN DIEGO — Patients treated with once-monthly efimosfermin 300 mg achieved significant improvements in metabolic dysfunction-associated steatohepatitis resolution and fibrosis at 24 weeks, according to late-breaking data.

SAN DIEGO — Patients with diabetes who were prescribed glucagon-like peptide-1 receptor agonists had lower odds of metabolic dysfunction-associated

SAN DIEGO — Semaglutide was superior to placebo in metabolic dysfunction-associated steatohepatitis resolution and improvement in fibrosis at 72